1α-Hydroxyvitamin D2 and 1α-hydroxyvitamin D 3 have anabolic effects on cortical bone, but induce intracortical remodeling at toxic doses in ovariectomized rats

Bone

Volumn 35, Issue 3, 2004, Pages 704-710

  Weber, Karin ^a   Kaschig, Cornelia ^a   Erben, Reinhold G ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bone remodeling; Cortical bone; Ovariectomy; Rats; Vitamin D

Indexed keywords

ALFACALCIDOL; DOXERCALCIFEROL; FLUOROCHROME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE METABOLISM; BONE REMODELING; CONTROLLED STUDY; CORTICAL BONE; DOSE RESPONSE; FEMALE; IN VIVO STUDY; LABELING INDEX; MORPHOMETRICS; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OVARIECTOMY; RAT;

ANABOLIC AGENTS; ANIMALS; BONE REMODELING; CHOLECALCIFEROL; ERGOCALCIFEROLS; FEMALE; OSTEOGENESIS; OVARIECTOMY; RATS; RATS, INBRED F344;

EID: 4344604516     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2004.04.011     Document Type: Article

References (36)

1. Erben R.G., Weiser H., Sinowatz F., Rambeck W.A., Zucker H. Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats. Calcif. Tissue Int. 50:1992;228-236
2. Erben R.G., Bromm S., Stangassinger M. Short-term prophylaxis against estrogen depletion-induced bone loss with calcitriol does not provide long-term beneficial effects on cancellous bone mass or structure in ovariectomized rats. Osteoporos. Int. 8:1998;82-91
3. Shiraishi A., Takeda S., Masaki T., Higuchi Y., Uchiyama Y., Kubodera N., et al. Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen. J. Bone Miner. Res. 15:2000;770-779
4. 3 on ovariectomy-induced cancellous bone loss in the rat. Calcif. Tissue Int. 60:1997;434-440
5. 3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow. Endocrinology. 138:1997;4629-4635
6. 3 on bone. Endocrinology. 139:1998;4319-4328
7. 3. J. Bone Miner. Res. 17:2002;1498-1511
8. 3 in ovariectomized rats. J. Bone Miner. Res. 16:2001;639-651
9. Tilyard M.W., Spears G.F., Thomson J., Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N. Engl. J. Med. 326:1992;357-362
10. Gallagher J.C., Goldgar D. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study. Ann. Intern. Med. 113:1990;649-655
11. 3. Bone Miner. 20:1993;223-234
12. Gallagher J.C., Fowler S.E., Detter J.R., Sherman S.S. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J. Clin. Endocrinol. Metab. 86:2001;3618-3628
13. Ott S.M., Chesnut C.H. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann. Intern. Med. 110:1989;267-274
14. Falch J.A., Odegaard O.R., Finnanger A.M., Matheson I. Postmenopausal osteoporosis: no effect of three years treatment with 1,25- dihydroxycholecalciferol. Acta Med. Scand. 221:1987;199-204
15. Erben R.G. Vitamin D analogs and bone. J. Musculoskelet. Neuron Interact. 2:2001;59-69
16. Baron R., Tross R., Vignery A. Evidence of sequential remodeling in rat trabecular bone: morphology, dynamic histomorphometry, and changes during skeletal maturation. Anat. Rec. 208:1984;137-145
17. Bentolila V., Boyce T.M., Fyhrie D.P., Drumb R., Skerry T.M., Schaffler M.B. Intracortical remodeling in adult rat long bones after fatigue loading. Bone. 23:1998;275-281
18. Ibbotson K.J., Orcutt C.M., D'Souza S.M., Paddock C.L., Arthur J.A., Jankowsky M.L., et al. Contrasting effects of parathyroid hormone and insulin-like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis. J. Bone Miner. Res. 7:1992;425-432
19. Lauritzen D.B., Balena R., Shea M., Seedor J.G., Markatos A., Le H.M., et al. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats. J. Bone Miner. Res. 8:1993;871-879
20. Uzawa T., Hori M., Ejiri S., Ozawa H. Comparison of the effects of intermittent and continuous administration of human parathyroid hormone(1-34) on rat bone. Bone. 16:1995;477-484
21. Turner R.T., Hannon K.S., Demers L.M., Buchanan J., Bell N.H. Differential effects of gonadal function on bone histomorphometry in male and female rats. J. Bone Miner. Res. 4:1989;557-563
22. Sato M., Zeng G.Q., Turner C.H. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats. Endocrinology. 138:1997;4330-4337
23. Oxlund B.S., Ortoft G., Andreassen T.T., Oxlund H. Low-intensity, high-frequency vibration appears to prevent the decrease in strength of the femur and tibia associated with ovariectomy of adult rats. Bone. 32:2003;69-77
24. Erben R.G., Brunner K.S., Breig B., Eberle J., Goldberg M., Hofbauer L.C. Skeletal effects of cyclosporin A are gender related in rats. Endocrinology. 144:2003;40-49
25. Shiraishi A., Higashi S., Masaki T., Saito M., Ito M., Ikeda S., et al. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis. Calcif. Tissue Int. 71:2002;69-79
26. 3. Science. 190:1975;576-578
27. Hunt R.D., Garcia F.G., Walsh R.J. A comparison of the toxicity of ergocalciferol and cholecalciferol in rhesus monkeys (Macaca mulatta). J. Nutr. 102:1972;975-986
28. 2 partially dissociates between preservation of cancellous bone mass and effects on calcium homeostasis in ovariectomized rats. Calcif. Tissue Int. 60:1997;449-456
29. 3 in the rat. Proc. Soc. Exp. Biol. Med. 178:1985;432-436
30. 3. J. Am. Vet. Med. Assoc. 182:1983;1358-1369
31. Schenk R.K., Olah A.J., Herrmann W. Preparation of calcified tissues for light microscopy. Dickson G.R. Methods of calcified tissue preparation. 1984;1-56 Elsevier, Amsterdam
32. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee. J. Bone Miner. Res. 2:1987;595-610
33. 3 and estrogen therapy on cortical bone mechanical properties in the ovariectomized rat model. Endocrinology. 137:1996;1358-1364
34. Geusens P., Dequeker J., Nijs J., Verstraeten A., Bramm E. Prevention and treatment of osteopenia in the ovariectomized rat: effect of combined therapy with estrogens, 1-alpha vitamin D, and prednisolone. Calcif. Tissue Int. 48:1991;127-137
35. 3 derivative, in rats. J. Toxicol. Sci. 24:1999;133-139
36. 3: increased bone but impaired mineralization. Endocrinology. 119:1986;2580-2585